Patents for C12P 21 - Preparation of peptides or proteins (112,499)
03/2008
03/12/2008EP1896573A1 Mutant cells suitable for recombinant polypeptide production
03/12/2008EP1896073A2 Anti-il-23 antibodies, compositions, methods and uses
03/12/2008EP1506317B1 Marker molecules associated with lung tumors
03/12/2008EP1390511B1 Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells
03/12/2008EP0972048B1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
03/12/2008EP0614374B2 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES
03/12/2008CN101142320A Methods of detecting a phenotype of a polymorphic protein
03/12/2008CN101142315A Cell observation aiding instrument and method of cell observation therewith
03/12/2008CN101139626A Method for producing human insulinogen C peptide
03/12/2008CN101139625A Ace inhibitory peptides from plant materials
03/12/2008CN101139624A Method for preparing sialic acid oligose peptide
03/12/2008CN101139623A High-density fermentation method for recombining ovary cancer- resistant peculiar mini antibody
03/12/2008CN101139622A Organic compound and new biological material (JZIY-LC06) for protein resource conversion by detoxification of toxic waste liquor
03/12/2008CN101139590A Hybrid expression of neisserial proteins
03/12/2008CN101139584A High-density fermentation method for recombinant human keratinized cell growth factor-2
03/12/2008CN101139583A Recombinant human growth hormone (rhGH) highly effective expression method
03/12/2008CN101139570A High-density fermentation method for HPV L1 protein prokaryotic expression
03/12/2008CN100374571C Regulatory sequences and expression system functioning in filamentous fungi
03/12/2008CN100374568C TAO protein kinases and methods of use thereof
03/12/2008CN100374562C Modified Cry3A toxins and nucleic acid sequences coding thereof
03/12/2008CN100374560C Configuration of high effect expression serum albumin yeast strain and fermentation purification technology
03/12/2008CN100374558C Unhairing protease and polynucleotide encoding same
03/12/2008CN100374466C Antibodies against human IL-12
03/12/2008CN100374457C Anti-IL-6 antibodies, compositions, methods and uses
03/12/2008CN100374456C Specific human antibodies for selective cancer therapy
03/12/2008CN100374197C Solid compositions for selective adsorption from complex mixtures
03/11/2008US7342110 Polynucleotides, host cells and vectors for antibodies against leukemia CD 33 antigen
03/11/2008US7342109 Used in diagnosis; small cell lung cancer, lung adenocarcinoma, T-cell lymophoblastic lymphoma, glioblastoma, gastric carcinoma, colon adenocarcinoma, prostate carcinoma, pancreatic carcinoma, esophagus epidermoid carcinoma and promonocytic leukemia
03/11/2008US7342105 Antibody and use thereof
03/11/2008US7342103 Comprises DNAX interferon-like receptor subunit (DIRS) polypeptide for use in diagnosis and treatment of inflammation and blood disorders
03/11/2008US7342102 Nucleotide sequences coding uncoupling protein for use in the diagnosis and treatment of nervous system disorders
03/11/2008US7342101 Immunization against Coccidioides spp. fungi, protein and peptide antigens
03/11/2008US7342096 PRO1879 polypeptide
03/11/2008US7342091 Soluble cyclic analogues of β amyloid peptide
03/11/2008US7342090 Peptide-mimetics are constrained in the three-dimensional structure to provide an increased immunogenicity to the epitope sequence
03/11/2008US7341996 Endothelial growth factor for use as diagnostic and preventative tool in treatment of cell proliferative disorders
03/11/2008US7341866 Gene expression patterns; diagnosis, therapy disease
03/11/2008US7341860 Regulated antigen delivery system (RADS)
03/11/2008US7341859 ADH from Rhodococcus erythropolis
03/11/2008US7341852 Methods of decoupling reaction scale and protein synthesis yield in batch mode
03/11/2008US7341851 IL-8 like protein
03/11/2008US7341850 Human LXRα variants
03/11/2008US7341848 Isomaltose synthase-knockout microorganism belonging eumycota
03/11/2008US7341842 TRP8, a transient receptor potential channel expressed in taste receptor cells
03/11/2008US7341740 Human mitochondrial proteins and polynucleotide encoding the proteins
03/11/2008US7341727 M. catarrhalis outer membrane protein-106 polypeptide, methods of eliciting an immune response comprising same
03/11/2008US7341722 Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment
03/11/2008CA2300358C Novel phytase
03/11/2008CA2126091C Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides
03/06/2008WO2008028117A2 Glp-2 mimetibodies, polypeptides, compositions, methods and uses
03/06/2008WO2008028002A1 Increasing nadph-dependent products
03/06/2008WO2008025744A1 Extra-cellular production of recombinant proteins
03/06/2008WO2008025165A1 Process for enzymatic hydrolysis of pretreated lignocellulosic feedstocks
03/06/2008WO2007084922A3 Compositions and methods for humanization and optimization of n-glycans in plants
03/06/2008WO2007053800A3 Charge-modified lysozyme antimicrobial compositions, surfactants, and methods for infections and cystic fibrosis
03/06/2008WO2003076568A3 Immunotherapeutics for biodefense
03/06/2008WO2001027311A3 Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1d gene
03/06/2008US20080060100 Polypeptide Having 5 Fatty Acid Desaturating Activity, Polynucleotide Coding for the Polypeptide, and Use Thereof
03/06/2008US20080060089 Process for producing exogenous protein in the milk of transgenic mammals and a process for purifying proteins therefrom
03/06/2008US20080058433 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
03/06/2008US20080058277 Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression
03/06/2008US20080058265 Methods and compositions for activated protein c with reduced anti-coagulant properties
03/06/2008US20080058262 rPA optimization
03/06/2008US20080058261 Protease susceptibility II
03/06/2008US20080058258 Growth Factor
03/06/2008US20080058256 Metalloproteinase polypeptide; in vivo lysis of blood clots; genetic engineering; gene expression
03/06/2008US20080058245 Cloning nucleic acids coded for therapy
03/06/2008US20080057566 Bacterial host cell for the direct expression of peptides
03/06/2008US20080057556 Using electromagnet insult to stimulate insulin production
03/06/2008US20080057540 Novel DKR polypeptides
03/06/2008US20080057539 Glutamate transporter associated proteins and methods of use thereof
03/06/2008US20080057538 Expression vector comprising heat shock protein for use as tool in improving heterologous gene expression; enhancing protein folding
03/06/2008US20080057537 Nucleic acid encoding polypeptide involved in cellular entrance of the PRRS virus
03/06/2008US20080057519 Monoclonal antibody specific for b-cell chronic lymphocytic leukemia cell surface protein; diagnosing cell proliferative disorders of blood
03/06/2008US20080057515 Beta-like glycoprotein hormone polypeptide and heterodimer
03/06/2008US20080057510 Human Vascular IBP-Like Growth Factor
03/06/2008US20080057492 Interacting site for gp41 on gp120 of hiv-1
03/06/2008US20080057156 Porphyrin containing lactic acid bacterial cells and use thereof
03/06/2008US20080057085 Unique DNA and polypeptide sequences based on the circumsporozoite protein of Plasmodium vivax
03/06/2008US20080057066 Methods and compositions for targeting relt
03/06/2008US20080057065 Phep, an Amino Acid Permease of Staphylococcus Aureus
03/06/2008US20080057064 Erbb3 Based Methods and Compositions for Treating Neoplasms
03/06/2008US20080057063 human monoclonal antibodies; diagnostics and treatment of diseases associated with the activity and/or overproduction of alpha V beta 6; cancer
03/06/2008US20080057056 Fc Variants with Increased Affinity for FcyRIIC
03/06/2008US20080057004 Albumin-insulin fusion proteins
03/06/2008US20080056997 preferential binding members against extracellular matrix proteins, especially scFv antibody molecules against peptide domains of the glycoprostien, conjugated with labels, cytotoxic molecules or cytokines, for use in diagnosis and treatment of cancer
03/06/2008CA2661568A1 Process for enzymatic hydrolysis of pretreated lignocellulosic feedstocks
03/05/2008EP1895017A2 Use of A33 antigens and JAM-IT
03/05/2008EP1895006A1 Interleukin-17 related mammalian cytokines. Polynucleotides encoding them. Uses
03/05/2008EP1895005A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
03/05/2008EP1895004A1 Human hippocalcin gene variant associated with cancers
03/05/2008EP1895002A1 Novel trypsin family serine proteases
03/05/2008EP1895001A1 Novel trypsin family serine proteases
03/05/2008EP1894998A1 Method for large scale production of virus antigen
03/05/2008EP1894006A2 Method for identifying modulators of keah6 useful for treating alzheimer's disease
03/05/2008EP1893768A2 Total amino acid stabilization during cell-free protein synthesis
03/05/2008EP1893754A2 Novel glutamic acid decarboxylase (gad) chimera and methods of use
03/05/2008EP1661913B1 Bioactive peptides derived from the proteins of egg white by means of enzymatic hydrolysis
03/05/2008EP1238985B1 Human type complementarity determining region transplantation antibody against ganglioside gd3 and derivatives of antibody against ganglioside gd3
03/05/2008EP1064360B1 Luciferases, gfp fluorescent proteins, their nucleic acids and the use thereof in diagnostics